220 related articles for article (PubMed ID: 30301480)
41. Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.
Vilar-Pereira G; Resende Pereira I; de Souza Ruivo LA; Cruz Moreira O; da Silva AA; Britto C; Lannes-Vieira J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4297-309. PubMed ID: 27161638
[TBL] [Abstract][Full Text] [Related]
42. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.
Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290
[TBL] [Abstract][Full Text] [Related]
43. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
44. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
[TBL] [Abstract][Full Text] [Related]
45. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
[TBL] [Abstract][Full Text] [Related]
46. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
[TBL] [Abstract][Full Text] [Related]
48. Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
Morilla MJ; Montanari JA; Prieto MJ; Lopez MO; Petray PB; Romero EL
Int J Pharm; 2004 Jul; 278(2):311-8. PubMed ID: 15196636
[TBL] [Abstract][Full Text] [Related]
49. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.
Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A
Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691
[TBL] [Abstract][Full Text] [Related]
50. Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
Cevey ÁC; Mirkin GA; Donato M; Rada MJ; Penas FN; Gelpi RJ; Goren NB
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):378-387. PubMed ID: 29040909
[TBL] [Abstract][Full Text] [Related]
51. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
[TBL] [Abstract][Full Text] [Related]
52. Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.
Morilla MJ; Romero EL
Nanomedicine (Lond); 2015 Feb; 10(3):465-81. PubMed ID: 25707979
[TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
[TBL] [Abstract][Full Text] [Related]
54. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
55. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
57. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
Bustamante JM; Craft JM; Crowe BD; Ketchie SA; Tarleton RL
J Infect Dis; 2014 Jan; 209(1):150-62. PubMed ID: 23945371
[TBL] [Abstract][Full Text] [Related]
58. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J
Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695
[TBL] [Abstract][Full Text] [Related]
59. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
[TBL] [Abstract][Full Text] [Related]
60. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
